Trial Profile

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone: An Outpatient Detoxification for Opioid Dependence.

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 13 Mar 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Naltrexone (Primary) ; Naltrexone (Primary) ; Buprenorphine/naloxone
Indications Opioid-related disorders
Focus Adverse reactions

Most Recent Events

12 Jun 2018 Status changed from recruiting to completed.
17 Apr 2017 Planned primary completion date changed from 1 Sep 2015 to 1 Sep 2017.
25 Nov 2014 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com